KMSTF
Price:
$3.21
Market Cap:
$125.73M
Kadimastem Ltd, an Israeli biopharmaceutical company, focuses on pioneering regenerative medicine therapies that utilize cells originating from human embryonic stem cells, primarily targeting neurodegenerative disorders. Its developmental pipeline features AstroRx, a clinical-grade human astrocyte therapy presently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions. Additionally, the company is developing IsletRx, a clinical-grade pancreatic islet cell therapy designed to treat diabetes. Founded in 2008, Kadimastem maintains its headquarters in Ness Ziona, Israel.
Industry
Biotechnology
IPO Date
2021-02-01
Stock Exchange
OTC
Ticker
KMSTF
According to Kadimastem Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 133.31M. This represents a change of 996.42% compared to the average of 12.16M of the last 4 quarters.
The mean historical Enterprise Value of Kadimastem Ltd over the last ten years is 122.50M. The current 133.31M Enterprise Value has changed 10.78% with respect to the historical average. Over the past ten years (40 quarters), KMSTF's Enterprise Value was at its highest in in the September 2021 quarter at 128.18B. The Enterprise Value was at its lowest in in the September 2024 quarter at 7.38M.
Average
122.50M
Median
84.66M
Minimum
14.45M
Maximum
374.57M
Discovering the peaks and valleys of Kadimastem Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 321.43%
Maximum Annual Enterprise Value = 374.57M
Minimum Annual Increase = -87.97%
Minimum Annual Enterprise Value = 14.45M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 80.44M | -69.23% |
| 2023 | 261.38M | -30.22% |
| 2022 | 374.57M | 321.43% |
| 2021 | 88.88M | 100.90% |
| 2020 | 44.24M | -44.66% |
| 2019 | 79.94M | 68.06% |
| 2018 | 47.57M | 229.17% |
| 2017 | 14.45M | -87.97% |
| 2016 | 120.08M | 5.87% |
| 2015 | 113.43M | 189.57% |
The current Enterprise Value of Kadimastem Ltd (KMSTF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
238.80M
5-year avg
169.90M
10-year avg
122.50M
Kadimastem Ltd’s Enterprise Value is greater than Organicell Regenerative Medicine, Inc. (19.05M), greater than OKYO Pharma Limited (54.28M), greater than OptiBiotix Health Plc (5.37M), greater than Antisense Therapeutics Limited (10.68K), greater than Sorrento Therapeutics, Inc. (111.37M), greater than PharmChem, Inc. (19.98M), less than American Hemp Ventures, Inc. (0), greater than Noxopharm Limited (27.81M), greater than Renalytix Plc (26.40M), greater than Yourgene Health Plc (27.05M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 19.05M | $19.97M | |
| 54.28M | $22.73M | |
| 5.37M | $20.06M | |
| 10.68K | $19.64M | |
| 111.37M | $16.54M | |
| 19.98M | $21.95M | |
| 0 | $16.47M | |
| 27.81M | $14.78M | |
| 26.40M | $22.55M | |
| 27.05M | $20.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kadimastem Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kadimastem Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kadimastem Ltd's Enterprise Value?
What is the highest Enterprise Value for Kadimastem Ltd (KMSTF)?
What is the 3-year average Enterprise Value for Kadimastem Ltd (KMSTF)?
What is the 5-year average Enterprise Value for Kadimastem Ltd (KMSTF)?
How does the current Enterprise Value for Kadimastem Ltd (KMSTF) compare to its historical average?